Esflurbiprofen / Mentha Oil Transdermal Patch 40mg (LOQOA tapes® / ロコアテープ)

Description

Product Overview / 商品概要

LOQOA Tapes Esflurbiprofen 40mg / Mentha Oil 36.2mg (ロコアテープ)
Generic: Esflurbiprofen / Mentha Oil / エスフルルビプロフェン・ハッカ油製剤
Therapeutic Category: Transdermal Analgesic and Anti-inflammatory Agent / 経皮吸収型鎮痛消炎剤
Manufactured by: Taisho Pharmaceutical Co., Ltd. / 大正製薬株式会社

Composition & Specification / 組成・規格

Active Ingredient: Esflurbiprofen 40mg, Japanese Pharmacopoeia Mentha Oil 36.2mg per patch (10cm×14cm, plaster 1.73g/140cm²) / 1枚10cm×14cm（膏体1.73g/140cm²）中 エスフルルビプロフェン40mg、日局ハッカ油36.2mg
Additives: Liquid paraffin, Styrene-isoprene-styrene block copolymer, Polyisobutylene, Ester gum HG, Propylene glycol dicaprylate, Dibutylhydroxytoluene, and 1 other ingredient / 流動パラフィン、スチレン・イソプレン・スチレンブロック共重合体、ポリイソブチレン、エステルガムHG、ジカプリル酸プロピレングリコール、ジブチルヒドロキシトルエン、その他1成分
Appearance: Colorless to pale yellow transparent plaster patch with a characteristic aroma; the plaster is spread on a backing and the plaster surface is covered with a liner. Identification code: TAISHO 630 (printed on inner bag).
外観: 無色～淡黄色透明膏体の貼付剤で、特異な芳香を有し、膏体は支持体に展延され、膏体面をライナーで被覆してある。識別コード：TAISHO 630（内袋に記載）

Indications / 効能効果

EN: Analgesic and anti-inflammatory treatment of osteoarthritis
JA: 変形性関節症における鎮痛・消炎

Dosage and Administration / 用法用量

EN: Apply one patch to the affected area once daily. Do not apply more than 2 patches simultaneously.
JA: 1日1回、患部に貼付する。同時に2枚を超えて貼付しないこと。

Contraindications / 禁忌

EN: Patients with peptic ulcer; patients with serious blood disorders; patients with serious hepatic impairment; patients with serious renal impairment; patients with serious cardiac insufficiency; patients with serious hypertension; patients with history of hypersensitivity to any component of this product or flurbiprofen; patients with aspirin-induced asthma or its history; patients receiving enoxacin hydrate, lomefloxacin, norfloxacin, or prulifloxacin; women in the late stages of pregnancy.
JA: 消化性潰瘍のある患者、重篤な血液の異常のある患者、重篤な肝機能障害のある患者、重篤な腎機能障害のある患者、重篤な心機能不全のある患者、重篤な高血圧症のある患者、本剤の成分又はフルルビプロフェンに対し過敏症の既往歴のある患者、アスピリン喘息又はその既往歴のある患者、エノキサシン水和物・ロメフロキサシン・ノルフロキサシン・プルリフロキサシンを投与中の患者、妊娠後期の女性

Regulatory Information / 規制情報

Approval No.: 22700AMX01021000
Sales Started: January 2016 / 2016年1月
Classification Code: 872649
Storage: Store at room temperature / 室温保存
Shelf Life: 24 months / 24箇月

Packaging / 包装

Main Package (for sale): 70 patches [7 patches (aluminum inner bag) x 10] / 70枚［7枚（アルミ内袋）×10］
Other Available Packages (by special order): 70 patches [7 patches (aluminum inner bag) x 10], 560 patches [7 patches (aluminum inner bag) x 80]

Full product insert (添付文書) is attached as a downloadable PDF. For detailed precautions, drug interactions, and safety information, please refer to the official package insert.